{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T12:52:38Z","timestamp":1795006358437,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Fundamental Research Funds for the Central Universities","award":["2042023kf0044"],"award-info":[{"award-number":["2042023kf0044"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["Nos.82270104"],"award-info":[{"award-number":["Nos.82270104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neutrophilic airway inflammation is a challenge in asthma management and is associated with poor patient prognosis. Mucin 1 (MUC1), which contains a cytoplasmic tail (MUC1-CT), has been found to mediate glucocorticoid sensitivity in asthma; however, its role in modulating neutrophilic airway inflammation in asthma remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human-induced sputum cells were collected from healthy participants (n\u2009=\u200912), patients with mild-to-moderate asthma (n\u2009=\u200934), and those with severe asthma (n\u2009=\u200918). In vitro human lung bronchial 1 epithelial cell line (BEAS-2B) was transfected with small interfering RNA against MUC1 (MUC1-siRNA) and then stimulated by lipopolysaccharide (LPS), where some cells were pretreated with a TLR4 inhibitor\u00a0(TAK-242). In vivo mouse model of asthmatic neutrophil airway inflammation was induced by ovalbumin (OVA)\/LPS. Some groups were intraperitoneally injected with MUC1-CT inhibitor\u00a0(GO-203) and\/or TAK-242 .<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mRNA expression of MUC1 was downregulated in the induced sputum of patients with asthma and correlated with asthmatic neutrophilic airway inflammation. The mRNA expressions of TLR4, MyD88, nucleotide-binding oligomerization domain-like pyrin domain-containing protein 3 (NLRP3), caspase-1, interleukin (IL)-18, and IL-1\u03b2 in induced sputum cells of patients with asthma were upregulated and related to the mRNA expression of MUC1. LPS activated the TLR4 pathway and NLRP3-mediated pyroptosis in BEAS-2B cells in vitro, which were significantly aggravated after MUC1-siRNA transfection. Furthermore, MUCl-CT interacted with TLR4, and the interaction between TLR4 and MyD88 was significantly increased after MUCl-siRNA transfection. Moreover, TAK-242 ameliorated TLR4\/MyD88\/nuclear factor kappa B (NF-\u03baB) pathway activation, NLRP3 inflammasome-mediated pyroptosis, and neutrophilic inflammation exacerbated by MUC1 downregulation. GO-203 exacerbated TLR4\/MyD88\/NF-\u03baB pathway activation in vivo, and NLRP3 inflammasome-mediated pyroptosis reduced in a mouse model of asthmatic neutrophil airway inflammation induced by OVA\/LPS; these pathological changes were partially alleviated after TAK-242 application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study revealed that MUC1 downregulation plays an important role in asthmatic neutrophilic airway inflammation. MUC1-CT reduces NLRP3 inflammasome-mediated pyroptosis by inhibiting the activation of the TLR4\/MyD88\/NF-\u03baB pathway, thereby attenuating neutrophil airway inflammation in patients with asthma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-023-02550-y","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T15:01:47Z","timestamp":1698246107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4\/MyD88\/NF-\u03baB pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Lu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengdou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"issue":"1","key":"2550_CR1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","volume":"11","author":"JL Simpson","year":"2006","unstructured":"Simpson JL, et al. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54\u201361.","journal-title":"Respirology"},{"issue":"3","key":"2550_CR2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/imcb.12522","volume":"100","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. The onset, development and pathogenesis of severe neutrophilic asthma. Immunol Cell Biol. 2022;100(3):144\u201359.","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"2550_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4168\/aair.2022.14.1.1","volume":"14","author":"N Kang","year":"2022","unstructured":"Kang N, Song WJ. Discovering biomarkers of Neutrophilic Asthma: a clinician\u2019s perspective. Allergy Asthma Immunol Res. 2022;14(1):1\u20134.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"2550_CR4","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","volume":"133","author":"WC Moore","year":"2014","unstructured":"Moore WC, et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol. 2014;133(6):1557\u201363e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2550_CR5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaci.2021.12.769","volume":"149","author":"Y Xie","year":"2022","unstructured":"Xie Y, et al. T(H)17 cells and corticosteroid insensitivity in severe asthma. J Allergy Clin Immunol. 2022;149(2):467\u201379.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2550_CR6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, et al. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6(1):128.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"2550_CR7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","volume":"43","author":"RC Coll","year":"2022","unstructured":"Coll RC, Schroder K, Pelegr\u00edn P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci. 2022;43(8):653\u201368.","journal-title":"Trends Pharmacol Sci"},{"key":"2550_CR8","doi-asserted-by":"crossref","first-page":"105531","DOI":"10.1016\/j.phrs.2021.105531","volume":"167","author":"X Zhu","year":"2021","unstructured":"Zhu X, et al. \u03b1Klotho protein has therapeutic activity in contrast-induced acute kidney injury by limiting NLRP3 inflammasome-mediated pyroptosis and promoting autophagy. Pharmacol Res. 2021;167:105531.","journal-title":"Pharmacol Res"},{"issue":"4","key":"2550_CR9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1183\/09031936.00105013","volume":"43","author":"JL Simpson","year":"2014","unstructured":"Simpson JL, et al. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma. Eur Respir J. 2014;43(4):1067\u201376.","journal-title":"Eur Respir J"},{"key":"2550_CR10","doi-asserted-by":"crossref","unstructured":"Kato K et al. MUC1: the first respiratory mucin with an anti-inflammatory function. J Clin Med, 2017. 6(12).","DOI":"10.3390\/jcm6120110"},{"issue":"2","key":"2550_CR11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/toxsci\/kfz099","volume":"170","author":"S Chen","year":"2019","unstructured":"Chen S, et al. Blockade of the NLRP3\/Caspase-1 Axis ameliorates Airway Neutrophilic inflammation in a Toluene Diisocyanate-Induced Murine Asthma Model. Toxicol Sci. 2019;170(2):462\u201375.","journal-title":"Toxicol Sci"},{"key":"2550_CR12","doi-asserted-by":"crossref","unstructured":"Chen L et al. Blockade of NLRP3\/Caspase-1\/IL-1\u03b2 Regulated Th17\/Treg Immune Imbalance and Attenuated the Neutrophilic Airway Inflammation in an Ovalbumin-Induced Murine Model of Asthma J Immunol Res, 2022. 2022: p.\u00a09444227.","DOI":"10.1155\/2022\/9444227"},{"issue":"6","key":"2550_CR13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1165\/rcmb.2008-0169TR","volume":"39","author":"KC Kim","year":"2008","unstructured":"Kim KC, Lillehoj EP. MUC1 mucin: a peacemaker in the lung. Am J Respir Cell Mol Biol. 2008;39(6):644\u20137.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2550_CR14","doi-asserted-by":"crossref","first-page":"108445","DOI":"10.1016\/j.intimp.2021.108445","volume":"103","author":"G Ou","year":"2022","unstructured":"Ou G, et al. HSP60 regulates the cigarette smoke-induced activation of TLR4-NF-\u03baB-MyD88 signalling pathway and NLRP3 inflammasome. Int Immunopharmacol. 2022;103:108445.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2550_CR15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/all.13546","volume":"74","author":"J Milara","year":"2019","unstructured":"Milara J, et al. Mucin 1 deficiency mediates corticosteroid insensitivity in asthma. Allergy. 2019;74(1):111\u201321.","journal-title":"Allergy"},{"issue":"4","key":"2550_CR16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","volume":"4","author":"WW Stevens","year":"2016","unstructured":"Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016;4(4):565\u201372.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"15","key":"2550_CR17","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1158\/0008-5472.CAN-08-0464","volume":"68","author":"N Agata","year":"2008","unstructured":"Agata N, et al. MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8. Cancer Res. 2008;68(15):6136\u201344.","journal-title":"Cancer Res"},{"key":"2550_CR18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.lfs.2019.02.013","volume":"221","author":"H Zhang","year":"2019","unstructured":"Zhang H, et al. Mucin 1 downregulation impairs the anti-necroptotic effects of glucocorticoids in human bronchial epithelial cells. Life Sci. 2019;221:168\u201377.","journal-title":"Life Sci"},{"issue":"9","key":"2550_CR19","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1002\/jcp.28148","volume":"234","author":"H Zhang","year":"2019","unstructured":"Zhang H, et al. MUC1 downregulation promotes TNF-\u03b1-induced necroptosis in human bronchial epithelial cells via regulation of the RIPK1\/RIPK3 pathway. J Cell Physiol. 2019;234(9):15080\u20138.","journal-title":"J Cell Physiol"},{"key":"2550_CR20","doi-asserted-by":"crossref","unstructured":"Wang YM et al. Mucin 1 Inhibits Ferroptosis and Sensitizes Vitamin E to Alleviate Sepsis-Induced Acute Lung Injury through GSK3\u03b2\/Keap1-Nrf2-GPX4 Pathway Oxid Med Cell Longev, 2022. 2022: p.\u00a02405943.","DOI":"10.1155\/2022\/2405943"},{"key":"2550_CR21","doi-asserted-by":"crossref","first-page":"114291","DOI":"10.1016\/j.ejmech.2022.114291","volume":"235","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Toll-like receptor 4 (TLR4) inhibitors: current research and prospective. Eur J Med Chem. 2022;235:114291.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"2550_CR22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-022-03337-3","volume":"20","author":"Z Wu","year":"2022","unstructured":"Wu Z, et al. Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4\/NF-kB signaling pathway. J Transl Med. 2022;20(1):130.","journal-title":"J Transl Med"},{"issue":"5","key":"2550_CR23","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s10753-021-01466-3","volume":"44","author":"B Ma","year":"2021","unstructured":"Ma B, et al. PI3K\/AKT\/mTOR and TLR4\/MyD88\/NF-\u03baB signaling inhibitors attenuate pathological mechanisms of allergic asthma. Inflammation. 2021;44(5):1895\u2013907.","journal-title":"Inflammation"},{"issue":"1","key":"2550_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10753-022-01715-z","volume":"46","author":"L Huang","year":"2023","unstructured":"Huang L, et al. PCSK9 promotes endothelial dysfunction during Sepsis Via the TLR4\/MyD88\/NF-\u03baB and NLRP3 pathways. Inflammation. 2023;46(1):115\u201328.","journal-title":"Inflammation"},{"issue":"2","key":"2550_CR25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s10753-021-01588-8","volume":"45","author":"SS Zhang","year":"2022","unstructured":"Zhang SS, et al. TLR4-IN-C34 inhibits lipopolysaccharide-stimulated inflammatory responses via Downregulating TLR4\/MyD88\/NF-\u03baB\/NLRP3 signaling pathway and reducing ROS Generation in BV2 cells. Inflammation. 2022;45(2):838\u201350.","journal-title":"Inflammation"},{"key":"2550_CR26","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2147\/DDDT.S222296","volume":"13","author":"YM Wang","year":"2019","unstructured":"Wang YM, et al. Paclitaxel alleviated sepsis-induced acute lung injury by activating MUC1 and suppressing TLR-4\/NF-\u03baB pathway. Drug Des Devel Ther. 2019;13:3391\u2013404.","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"2550_CR27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/SHK.0000000000001742","volume":"56","author":"JB Gibier","year":"2021","unstructured":"Gibier JB, et al. MUC1 mitigates renal Injury and inflammation in Endotoxin-Induced Acute kidney Injury by inhibiting the TLR4-MD2 Axis and reducing pro-inflammatory macrophages infiltration. Shock. 2021;56(4):629\u201338.","journal-title":"Shock"},{"key":"2550_CR28","doi-asserted-by":"crossref","unstructured":"Reddel HK et al. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. Eur Respir J, 2022. 59(1).","DOI":"10.1183\/13993003.02730-2021"},{"issue":"4","key":"2550_CR29","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.4049\/jimmunol.1102405","volume":"188","author":"K Kato","year":"2012","unstructured":"Kato K, et al. Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88. J Immunol. 2012;188(4):2014\u201322.","journal-title":"J Immunol"},{"issue":"3","key":"2550_CR30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1165\/rcmb.2014-0018OC","volume":"51","author":"K Kato","year":"2014","unstructured":"Kato K, Lillehoj EP, Kim KC. MUC1 regulates epithelial inflammation and apoptosis by PolyI:C through inhibition of Toll\/IL-1 receptor-domain-containing adapter-inducing IFN-\u03b2 (TRIF) recruitment to toll-like receptor 3. Am J Respir Cell Mol Biol. 2014;51(3):446\u201354.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"2550_CR31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1165\/rcmb.2007-0336RC","volume":"38","author":"K Ueno","year":"2008","unstructured":"Ueno K, et al. MUC1 mucin is a negative regulator of toll-like receptor signaling. Am J Respir Cell Mol Biol. 2008;38(3):263\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"2550_CR32","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1158\/1078-0432.CCR-14-3000","volume":"21","author":"M Hasegawa","year":"2015","unstructured":"Hasegawa M, et al. Intracellular targeting of the oncogenic MUC1-C protein with a Novel GO-203 nanoparticle formulation. Clin Cancer Res. 2015;21(10):2338\u201347.","journal-title":"Clin Cancer Res"},{"key":"2550_CR33","doi-asserted-by":"crossref","first-page":"106438","DOI":"10.1016\/j.intimp.2020.106438","volume":"83","author":"YM Wang","year":"2020","unstructured":"Wang YM, et al. Protective and predictive role of Mucin1 in sepsis-induced ALI\/ARDS. Int Immunopharmacol. 2020;83:106438.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"2550_CR34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/all.13985","volume":"75","author":"E Sze","year":"2020","unstructured":"Sze E, Bhalla A, Nair P. Mechanisms and therapeutic strategies for non-T2 asthma. Allergy. 2020;75(2):311\u201325.","journal-title":"Allergy"},{"issue":"3","key":"2550_CR35","doi-asserted-by":"crossref","first-page":"152086","DOI":"10.1016\/j.imbio.2021.152086","volume":"226","author":"AK Mavi","year":"2021","unstructured":"Mavi AK, et al. Expression profile of MUC1 protein in Pigeon allergens positive asthmatic. Immunobiology. 2021;226(3):152086.","journal-title":"Immunobiology"},{"issue":"6","key":"2550_CR36","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jaci.2021.04.022","volume":"147","author":"EJ Williams","year":"2021","unstructured":"Williams EJ, Negewo NA, Baines KJ. Role of the NLRP3 inflammasome in asthma: relationship with neutrophilic inflammation, obesity, and therapeutic options. J Allergy Clin Immunol. 2021;147(6):2060\u20132.","journal-title":"J Allergy Clin Immunol"},{"key":"2550_CR37","doi-asserted-by":"crossref","first-page":"1039997","DOI":"10.3389\/fimmu.2023.1039997","volume":"14","author":"KN Killian","year":"2023","unstructured":"Killian KN, et al. RAGE contributes to allergen driven severe neutrophilic airway inflammation via NLRP3 inflammasome activation in mice. Front Immunol. 2023;14:1039997.","journal-title":"Front Immunol"},{"issue":"9","key":"2550_CR38","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/rccm.201810-1869OC","volume":"199","author":"ME Lachowicz-Scroggins","year":"2019","unstructured":"Lachowicz-Scroggins ME, et al. Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome activation in severe asthma. Am J Respir Crit Care Med. 2019;199(9):1076\u201385.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2550_CR39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.18632\/aging.203824","volume":"14","author":"D Chen","year":"2022","unstructured":"Chen D, et al. Atorvastatin suppresses NLRP3 inflammasome activation in intracerebral hemorrhage via TLR4- and MyD88-dependent pathways. Aging. 2022;14(1):462\u201376.","journal-title":"Aging"},{"key":"2550_CR40","doi-asserted-by":"crossref","first-page":"760331","DOI":"10.3389\/fphar.2021.760331","volume":"12","author":"X Ouyang","year":"2021","unstructured":"Ouyang X, et al. Active flavonoids from Lagotis brachystachya Attenuate Monosodium Urate-Induced Gouty Arthritis via inhibiting TLR4\/MyD88\/NF-\u03baB pathway and NLRP3 expression. Front Pharmacol. 2021;12:760331.","journal-title":"Front Pharmacol"},{"key":"2550_CR41","doi-asserted-by":"crossref","first-page":"107621","DOI":"10.1016\/j.intimp.2021.107621","volume":"96","author":"Y Wu","year":"2021","unstructured":"Wu Y, et al. Suppression of NLRP3 inflammasome by Platycodin D via the TLR4\/MyD88\/NF-\u03baB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats. Int Immunopharmacol. 2021;96:107621.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"2550_CR42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000254790","volume":"2","author":"MA Williams","year":"2010","unstructured":"Williams MA, et al. Deletion of the mucin-like molecule muc1 enhances dendritic cell activation in response to toll-like receptor ligands. J Innate Immun. 2010;2(2):123\u201343.","journal-title":"J Innate Immun"},{"issue":"7","key":"2550_CR43","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/gutjnl-2014-307175","volume":"65","author":"GZ Ng","year":"2016","unstructured":"Ng GZ, et al. The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome. Gut. 2016;65(7):1087\u201399.","journal-title":"Gut"},{"issue":"3","key":"2550_CR44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/gene.2016.10","volume":"17","author":"GZ Ng","year":"2016","unstructured":"Ng GZ, Sutton P. The MUC1 mucin specifically inhibits activation of the NLRP3 inflammasome. Genes Immun. 2016;17(3):203\u20136.","journal-title":"Genes Immun"},{"issue":"2","key":"2550_CR45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1165\/rcmb.2011-0142OC","volume":"46","author":"Y Kyo","year":"2012","unstructured":"Kyo Y, et al. Antiinflammatory role of MUC1 mucin during infection with nontypeable Haemophilus influenzae. Am J Respir Cell Mol Biol. 2012;46(2):149\u201356.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"2550_CR46","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1158\/0008-5472.CAN-15-1804","volume":"76","author":"A Bouillez","year":"2016","unstructured":"Bouillez A, et al. Inhibition of MUC1-C suppresses MYC expression and attenuates malignant growth in KRAS Mutant Lung Adenocarcinomas. Cancer Res. 2016;76(6):1538\u201348.","journal-title":"Cancer Res"},{"issue":"8","key":"2550_CR47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1398-9995.2011.02586.x","volume":"66","author":"AG Besnard","year":"2011","unstructured":"Besnard AG, et al. NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy. 2011;66(8):1047\u201357.","journal-title":"Allergy"},{"issue":"2","key":"2550_CR48","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2017.02.045","volume":"141","author":"C Rossios","year":"2018","unstructured":"Rossios C, et al. Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthma. J Allergy Clin Immunol. 2018;141(2):560\u201370.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2550_CR49","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1124\/pharmrev.120.000171","volume":"73","author":"SE Corcoran","year":"2021","unstructured":"Corcoran SE, Halai R, Cooper MA. Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950. Pharmacol Rev. 2021;73(3):968\u20131000.","journal-title":"Pharmacol Rev"},{"key":"2550_CR50","doi-asserted-by":"crossref","unstructured":"Theofani E et al. Targeting NLRP3 inflammasome activation in severe asthma. J Clin Med, 2019. 8(10).","DOI":"10.3390\/jcm8101615"},{"issue":"1","key":"2550_CR51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1248\/bpb.b19-00095","volume":"43","author":"T Nabe","year":"2020","unstructured":"Nabe T. Steroid-resistant asthma and neutrophils. Biol Pharm Bull. 2020;43(1):31\u20135.","journal-title":"Biol Pharm Bull"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02550-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-023-02550-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02550-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T01:04:55Z","timestamp":1700269495000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-023-02550-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2550"],"URL":"https:\/\/doi.org\/10.1186\/s12931-023-02550-y","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"assertion":[{"value":"20 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal care and experimental procedures were approved by the Animal Care and Use Committee of the Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. All experiments involving animals were approved by the Ethics Committee of Tongji Hospital (IRB: TJ-IRB20220663). All recruited subjects signed written informed consent forms before their inclusion in the study, which conformed to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}